Impact of extended cycles of chemotherapy on survival outcome in recurrent epithelial ovarian cancer

被引：0
|
作者：
Hwang, W. Y. [1 ]
Kim, S. I. [2 ]
Lee, M. [2 ]
Kim, K. [1 ]
No, J. H. [1 ]
Kim, J. W. [2 ]
Kim, Y. B. [1 ]
Suh, D. H. [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Seongnam Si, South Korea
[2] Seoul Natl Univ Hosp, Seoul, South Korea
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.644
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
756
引用
收藏
页码：346 / 347
页数：2
相关论文
共 50 条
  • [21] Does sites of recurrence impact survival in secondary cytoreduction surgery for recurrent epithelial ovarian cancer?
    Kumar, Satyam
    Srinivasan, Ananth
    Phillips, Andrew
    Madhupriya, R.
    Pascoe, Jennifer
    Nevin, James
    Elattar, Ahmed
    Balega, Janos
    Cummins, Carole
    Sundar, Sudha
    Kehoe, Sean T.
    Singh, Kavita
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 40 (06) : 849 - 855
  • [22] Impact from primary and recurrent treatment on survival of FIGO IIIc epithelial ovarian cancer patients
    Szczesny, Witold
    Vistad, Ingvild
    Kaern, Janne
    Nakling, Jakob
    Sandvik, Leiv
    Trope, Claes
    Paulsen, Torbjern
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [23] Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
    Baruah, Upasana
    Barmon, Debabrata
    Kataki, Amal Chandra
    Deka, Pankaj
    Hazarika, Munlima
    Saikia, Bhargab J.
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2015, 36 (01) : 38 - 42
  • [24] Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer - Analysis of prognostic factors and survival outcome
    Salani, Ritu
    Santillan, Antonio
    Zahurak, Marianna L.
    Giuntoli, Robert L., II
    Gardner, Ginger J.
    Armstrong, Deborah K.
    Bristow, Robert E.
    CANCER, 2007, 109 (04) : 685 - 691
  • [25] Impact of bowel resection on overall survival after neoadjuvant chemotherapy in advanced epithelial ovarian cancer
    Philip, C. A.
    Pelissier, A.
    Bonneau, C.
    Dubot, C.
    De la Motte Rouge, T.
    Nicolas, P.
    Roman, R.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S544 - S544
  • [26] THE IMPACT OF THE INTERVAL FROM SURGERY TO INITIATION OF CHEMOTHERAPY (ISC) ON SURVIVAL IN ADVANCED EPITHELIAL OVARIAN CANCER
    Heo, E. J.
    Lee, Y. Y.
    Kim, T. J.
    Choi, J. K.
    Kim, T. H.
    Yun, G.
    Choi, C. H.
    Lee, J. W.
    Bae, D. S.
    Kim, B. G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 209 - 209
  • [27] The impact of chemotherapy on the survival of early-stage I-II epithelial ovarian cancer
    Urban, R.
    Deshmukh, H.
    Zhang, R.
    Yu, X.
    Shin, J. Y.
    Osann, K.
    Kapp, D. S.
    Husain, A.
    Chen, L.
    Chan, J. K.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (02) : 382 - 382
  • [28] EPITHELIAL OVARIAN-CANCER - IMPACT OF SURGERY AND CHEMOTHERAPY ON SURVIVAL DURING 1977-1990
    VENESMAA, P
    OBSTETRICS AND GYNECOLOGY, 1994, 84 (01): : 8 - 11
  • [29] IMPACT OF NEOADJUVANT CHEMOTHERAPY ON SURVIVAL IN ADVANCE EPITHELIAL OVARIAN CANCER SUBOPTIMALLY DEBULKED AT INTERVAL SURGERY
    Le, T.
    AlMutairi, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 53 - 53
  • [30] Impact of chemotherapy on the survival of early-stage I-II epithelial ovarian cancer
    Urban, R.
    Deshmukh, H.
    Zhang, R.
    Yu, X.
    Shin, J. Y.
    Osann, K.
    Kapp, D. S.
    Husain, A.
    Chen, L.
    Chan, J. K.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S59 - S60
12345